Year-long effort brings in Talcid for BBDO/CNUAC

<p>SHANGHAI: BBDO/CNUAC has dealt a blow to Dentsu Young & Rubicam by </p><p>snagging the Bayer China's over-the-counter antacid brand Talcid, an </p><p>account estimated to be worth about USdollars 2 million. </p><p><BR><BR> </p><p>BBDO, which is Bayer's regional agency, took the account after a </p><p>year-long effort to lure the client away from DY&R culminated in a pitch </p><p>that focused on creative and strategic credentials. </p><p><BR><BR> </p><p>BBDO/CNUAC Shanghai managing director Lau Seng Yee said an integrated </p><p>campaign is being planned. </p><p><BR><BR> </p><p>"We will produce a campaign driven primarily by a series of TV </p><p>commercials. In addition, the campaign will be supported with integrated </p><p>elements both at the consumer level as well as the prescription channel. </p><p>The objective of the campaign is to reinforce the fast relief function </p><p>of the product." </p><p><BR><BR> </p>

SHANGHAI: BBDO/CNUAC has dealt a blow to Dentsu Young & Rubicam by

snagging the Bayer China's over-the-counter antacid brand Talcid, an

account estimated to be worth about USdollars 2 million.



BBDO, which is Bayer's regional agency, took the account after a

year-long effort to lure the client away from DY&R culminated in a pitch

that focused on creative and strategic credentials.



BBDO/CNUAC Shanghai managing director Lau Seng Yee said an integrated

campaign is being planned.



"We will produce a campaign driven primarily by a series of TV

commercials. In addition, the campaign will be supported with integrated

elements both at the consumer level as well as the prescription channel.

The objective of the campaign is to reinforce the fast relief function

of the product."